Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:08PM ET
27.35
Dollar change
+0.72
Percentage change
2.70
%
IndexRUT P/E52.71 EPS (ttm)0.52 Insider Own14.82% Shs Outstand62.98M Perf Week-0.58%
Market Cap1.98B Forward P/E- EPS next Y-2.26 Insider Trans-0.06% Shs Float61.59M Perf Month-12.81%
Income40.72M PEG- EPS next Q-0.76 Inst Own80.88% Short Float9.62% Perf Quarter-25.13%
Sales216.67M P/S9.13 EPS this Y-603.65% Inst Trans0.41% Short Ratio6.56 Perf Half Y0.04%
Book/sh7.60 P/B3.60 EPS next Y17.06% ROA5.46% Short Interest5.92M Perf Year12.64%
Cash/sh6.48 P/C4.22 EPS next 5Y-4.30% ROE8.17% 52W Range20.76 - 59.24 Perf YTD-23.60%
Dividend Est.- P/FCF- EPS past 5Y- ROI6.17% 52W High-53.83% Beta1.56
Dividend TTM- Quick Ratio4.25 Sales past 5Y26.65% Gross Margin64.93% 52W Low31.74% ATR (14)1.42
Dividend Ex-Date- Current Ratio4.25 EPS Y/Y TTM127.63% Oper. Margin-81.90% RSI (14)51.53 Volatility4.50% 5.36%
Employees867 Debt/Eq0.23 Sales Y/Y TTM19.73% Profit Margin18.79% Recom1.60 Target Price37.70
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q-11.43% Payout0.00% Rel Volume0.44 Prev Close26.63
Sales Surprise-6.34% EPS Surprise20.02% Sales Q/Q30.40% EarningsFeb 28 AMC Avg Volume902.47K Price27.35
SMA204.66% SMA50-0.20% SMA200-17.89% Trades Volume172,096 Change2.70%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated KeyBanc Capital Markets Overweight $38
May-05-23Resumed Piper Sandler Overweight $60
Dec-19-22Initiated Goldman Neutral $23
Mar-01-22Initiated Citigroup Buy $55
Nov-19-21Initiated Piper Sandler Overweight $87
Nov-19-21Downgrade Morgan Stanley Overweight → Equal-Weight $82 → $49
Nov-11-21Downgrade BofA Securities Buy → Neutral $80 → $52
Oct-13-21Initiated Berenberg Buy $91
Sep-01-21Upgrade Morgan Stanley Equal-Weight → Overweight $82
May-25-21Initiated Craig Hallum Buy $85
Mar-24-24 08:16AM
Mar-20-24 10:27AM
Mar-19-24 08:30AM
Mar-18-24 05:50AM
Mar-01-24 07:30AM
01:50PM Loading…
Feb-29-24 01:50PM
10:04AM
Feb-28-24 10:30PM
05:55PM
04:40PM
04:05PM
Feb-26-24 09:15AM
Feb-25-24 09:32PM
Feb-20-24 08:30AM
Feb-19-24 05:13PM
08:30AM Loading…
Feb-16-24 08:30AM
Feb-14-24 08:30AM
Jan-19-24 08:30AM
Jan-08-24 07:30AM
Dec-29-23 02:37AM
Dec-19-23 08:30AM
Dec-14-23 07:04AM
Dec-11-23 08:01AM
Dec-10-23 12:00PM
Nov-17-23 08:30AM
Nov-14-23 12:06AM
Nov-09-23 07:11PM
Nov-06-23 08:30AM
Nov-04-23 09:00AM
Nov-02-23 03:59PM
10:33AM Loading…
10:33AM
09:00AM
08:15AM
Nov-01-23 06:58PM
06:30PM
04:00PM
Oct-30-23 08:30AM
Oct-27-23 12:31PM
Oct-25-23 06:50AM
Oct-23-23 08:30AM
Oct-18-23 08:30AM
02:59AM
Oct-16-23 05:50AM
Oct-09-23 02:46PM
Oct-08-23 07:19PM
Sep-28-23 05:00PM
08:30AM
08:00AM
Sep-26-23 01:33PM
Sep-25-23 05:50AM
Sep-18-23 08:30AM
Sep-15-23 08:45AM
Sep-13-23 05:50AM
Sep-05-23 08:30AM
Aug-29-23 10:07PM
Aug-23-23 07:42PM
Aug-11-23 08:30AM
Aug-07-23 10:59AM
Aug-04-23 06:00AM
Aug-03-23 08:17PM
Aug-02-23 07:15PM
04:00PM
Jul-26-23 04:24PM
10:02AM
Jul-21-23 10:07AM
Jul-20-23 08:30AM
Jul-19-23 08:30AM
Jul-18-23 10:00AM
09:54AM
Jul-17-23 10:15AM
Jul-11-23 12:27PM
10:07AM
Jul-03-23 08:43AM
Jun-22-23 08:00AM
Jun-21-23 08:52PM
Jun-20-23 08:18AM
Jun-16-23 01:20PM
06:24AM
Jun-14-23 08:01PM
09:23AM
Jun-02-23 06:46PM
Jun-01-23 08:30AM
May-26-23 03:24PM
08:30AM
May-25-23 08:30AM
May-23-23 06:28AM
May-18-23 04:40PM
May-14-23 02:57PM
May-09-23 07:52AM
May-08-23 06:00AM
May-05-23 02:06PM
09:23AM
07:06AM
May-04-23 05:15PM
04:00PM
Apr-27-23 07:00AM
Apr-20-23 08:30AM
Apr-19-23 08:30AM
Apr-14-23 08:52AM
Mar-27-23 11:28AM
Schrodinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareMar 06 '24Option Exercise4.345,57424,19142,061Mar 07 05:05 PM
Porges Geoffrey CraigEVP & CFOMar 04 '24Sale26.353,31587,3605,685Mar 05 05:13 PM
Abel Robert LorneSee RemarksFeb 12 '24Sale27.551,20533,1989,340Feb 13 07:37 PM
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareFeb 12 '24Sale28.2990125,48936,487Feb 13 07:35 PM
Herman JennySVP & ControllerFeb 12 '24Sale28.2978722,26411,761Feb 13 07:36 PM
Tran YvonneEVP, CLO & CPOFeb 12 '24Sale28.2975821,44411,963Feb 13 07:39 PM
Herman JennySVP & ControllerSep 15 '23Option Exercise1.204,5455,45412,548Sep 18 04:36 PM
Lorton Kenneth PatrickEVP & Chief Technology OfficerAug 09 '23Sale40.0610,000400,64237,388Aug 10 04:37 PM
Tran YvonneEVP, CLO & CPOJun 30 '23Option Exercise17.0012,040204,68024,761Jul 03 04:16 PM
Tran YvonneEVP, CLO & CPOJun 30 '23Sale50.0012,040602,00012,721Jul 03 04:16 PM
Tran YvonneEVP, CLO & CPOMay 23 '23Option Exercise4.347,96034,54620,681May 24 05:19 PM
Lorton Kenneth PatrickEVP & Chief Technology OfficerMay 23 '23Sale40.0610,000400,58747,388May 24 05:16 PM
Tran YvonneEVP, CLO & CPOMay 23 '23Sale40.017,960318,46112,721May 24 05:19 PM
Thornberry NancyDirectorMay 22 '23Option Exercise11.5214,850171,07214,850May 23 05:05 PM
Tran YvonneEVP, CLO & CPOMay 22 '23Option Exercise4.3315,00064,96327,721May 24 05:19 PM
Tran YvonneEVP, CLO & CPOMay 22 '23Sale35.0415,000525,63212,721May 24 05:19 PM
Thornberry NancyDirectorMay 22 '23Sale35.0014,850519,7500May 23 05:05 PM